Topical chemical carcinogen treatment in mice

J Curran¹

Affiliations

J Curran. Methods Mol Biol. 2001.

. 2001:174:391-9.

doi: 10.1385/1-59259-227-9:391.

J Curran¹

¹ Athena Diagnostics, Inc., Division of Elar Pharmaceuticals, Worcester, MA, USA.

No abstract available

Similar articles

Genetically altered mouse models for identifying carcinogens.
Tennant RW, Stasiewicz S, Mennear J, French JE, Spalding JW. Tennant RW, et al. IARC Sci Publ. 1999;(146):123-50. IARC Sci Publ. 1999. PMID: 10353386 Review. No abstract available.
Animal models and the molecular pathology of cancer.
Lovejoy EA, Clarke AR, Harrison DJ. Lovejoy EA, et al. J Pathol. 1997 Feb;181(2):130-5. doi: 10.1002/(SICI)1096-9896(199702)181:2<130::AID-PATH754>3.0.CO;2-F. J Pathol. 1997. PMID: 9120714 Review. No abstract available.
The natural history of carcinogenesis: implications of experimental carcinogenesis in the genesis of human cancer.
Pitot HC, Goldsworthy T, Moran S. Pitot HC, et al. J Supramol Struct Cell Biochem. 1981;17(2):133-46. doi: 10.1002/jsscb.380170204. J Supramol Struct Cell Biochem. 1981. PMID: 7033553 Review. No abstract available.
Transgenic mouse models for the identification of human carcinogens: a European perspective.
van Kreijl CF, van Steeg H. van Kreijl CF, et al. Toxicol Pathol. 1998 Nov-Dec;26(6):757-8. doi: 10.1177/019262339802600607. Toxicol Pathol. 1998. PMID: 9864092 No abstract available.
[Significance of carcinogenesis in vitro by chemical carcinogens].
Kamahora J, Kakunaga T. Kamahora J, et al. Tanpakushitsu Kakusan Koso. 1970 Apr;15(5):458-73. Tanpakushitsu Kakusan Koso. 1970. PMID: 4913824 Review. Japanese. No abstract available.